Citadel Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Sell
34,800
-71,300
-67% -$3.25M ﹤0.01% 6677
2025
Q4
$4.7M Sell
106,100
-437,100
-80% -$18.8M ﹤0.01% 4385
2025
Q3
$22.9M Buy
543,200
+423,700
+355% +$17.1M ﹤0.01% 2158
2025
Q2
$4.38M Buy
119,500
+9,900
+9% +$368K ﹤0.01% 4349
2025
Q1
$4.17M Buy
109,600
+47,000
+75% +$1.75M ﹤0.01% 4183
2024
Q4
$2.37M Buy
62,600
+24,200
+63% +$967K ﹤0.01% 5283
2024
Q3
$1.56M Sell
38,400
-86,000
-69% -$3.25M ﹤0.01% 5980
2024
Q2
$4.26M Buy
124,400
+78,400
+170% +$2.47M ﹤0.01% 4001
2024
Q1
$1.46M Sell
46,000
-124,500
-73% -$3.78M ﹤0.01% 6146
2023
Q4
$5.23M Sell
170,500
-41,600
-20% -$1.33M ﹤0.01% 3716
2023
Q3
$7.03M Buy
212,100
+6,600
+3% +$211K ﹤0.01% 3152
2023
Q2
$6.31M Buy
205,500
+24,500
+14% +$708K ﹤0.01% 3296
2023
Q1
$4.96M Sell
181,000
-38,100
-17% -$1.06M ﹤0.01% 3831
2022
Q4
$6.12M Buy
219,100
+102,700
+88% +$3.1M ﹤0.01% 3532
2022
Q3
$3.43M Sell
116,400
-15,700
-12% -$492K ﹤0.01% 4539
2022
Q2
$3.72M Sell
132,100
-228,900
-63% -$6.51M ﹤0.01% 4354
2022
Q1
$11.2M Buy
361,000
+122,400
+51% +$3.61M ﹤0.01% 2763
2021
Q4
$7.06M Sell
238,600
-10,700
-4% -$312K ﹤0.01% 3701
2021
Q3
$7.47M Buy
249,300
+89,900
+56% +$3.09M ﹤0.01% 3573
2021
Q2
$5.79M Buy
159,400
+53,200
+50% +$1.98M ﹤0.01% 4121
2021
Q1
$3.89M Sell
106,200
-59,000
-36% -$2.17M ﹤0.01% 4829
2020
Q4
$6M Sell
165,200
-46,400
-22% -$1.57M ﹤0.01% 3375
2020
Q3
$6.33M Sell
211,600
-82,900
-28% -$2.59M ﹤0.01% 2836
2020
Q2
$8.76M Buy
294,500
+53,500
+22% +$1.58M ﹤0.01% 2379
2020
Q1
$6.4M Buy
241,000
+39,900
+20% +$1.51M ﹤0.01% 2406
2019
Q4
$8.52M Sell
201,100
-69,300
-26% -$2.93M ﹤0.01% 2388
2019
Q3
$11.3M Buy
270,400
+47,000
+21% +$1.83M 0.01% 2076
2019
Q2
$8.21M Buy
223,400
+8,200
+4% +$299K ﹤0.01% 2419
2019
Q1
$8.21M Buy
215,200
+34,800
+19% +$1.29M ﹤0.01% 2306
2018
Q4
$6.34M Buy
180,400
+19,800
+12% +$687K ﹤0.01% 2468
2018
Q3
$5.26M Buy
160,600
+52,800
+49% +$1.68M ﹤0.01% 2938
2018
Q2
$3.34M Sell
107,800
-73,300
-40% -$2.09M ﹤0.01% 3318
2018
Q1
$4.9M Sell
181,100
-449,500
-71% -$12M ﹤0.01% 2482
2017
Q4
$17.4M Buy
630,600
+425,200
+207% +$12.3M 0.01% 1247
2017
Q3
$6.55M Buy
205,400
+123,500
+151% +$3.96M 0.01% 2009
2017
Q2
$2.7M Buy
81,900
+54,200
+196% +$1.79M ﹤0.01% 2775
2017
Q1
$914K Buy
27,700
+4,100
+17% +$132K ﹤0.01% 4136
2016
Q4
$738K Buy
23,600
+8,100
+52% +$250K ﹤0.01% 4303
2016
Q3
$549K Buy
15,500
+300
+2% +$10.7K ﹤0.01% 4719
2016
Q2
$516K Buy
+15,200
New +$507K ﹤0.01% 4439
2016
Q1
Sell
-36,300
Closed -$1.27M 7611
2015
Q4
$1.27M Buy
36,300
+28,300
+354% +$977K ﹤0.01% 3289
2015
Q3
$281K Sell
8,000
-22,900
-74% -$804K ﹤0.01% 5667
2015
Q2
$1.06M Buy
30,900
+18,200
+143% +$668K ﹤0.01% 3893
2015
Q1
$515K Buy
12,700
+8,800
+226% +$364K ﹤0.01% 4865
2014
Q4
$152K Sell
3,900
-200
-5% -$7.58K ﹤0.01% 6277
2014
Q3
$140K Sell
4,100
-1,600
-28% -$58.9K ﹤0.01% 6078
2014
Q2
$210K Sell
5,700
-1,300
-19% -$46.4K ﹤0.01% 5514
2014
Q1
$235K Sell
7,000
-2,600
-27% -$82.8K ﹤0.01% 5336
2013
Q4
$286K Sell
9,600
-39,700
-81% -$1.26M ﹤0.01% 4650
2013
Q3
$1.47M Buy
49,300
+36,300
+279% +$1.1M ﹤0.01% 2684
2013
Q2
$403K Buy
+13,000
New +$427K ﹤0.01% 4050

Other funds holding OHI

Citadel Advisors's OHI Position: Q1 2026 in Review

Citadel Advisors sold out of Omega Healthcare (OHI) in Q1 2026, closing a stake of 135,153 shares — an estimated $6.17M sold.

Citadel Advisors first reported a position in OHI in Q2 2013 and held it in 47 quarters. The position peaked at $52.8M in Q1 2017. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Citadel Advisors reported no remaining Omega Healthcare position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 135,153 Omega Healthcare shares in Q1 2026, an estimated $6.17M.
  • Citadel Advisors first reported a position in Omega Healthcare in Q2 2013 and held it in 47 quarters.
  • Citadel Advisors's Omega Healthcare position peaked at $52.8M in Q1 2017.
  • 743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.